Literature DB >> 32894441

Patient, Physician, and Procedure Characteristics Are Independently Predictive of Polyp Detection Rates in Clinical Practice.

Nicole G Jawitz1, Ziad F Gellad1,2, Li Lin3, Richard K Wood1, David A Leiman4,5.   

Abstract

BACKGROUND: Variability in colon polyp detection impacts patient outcomes. However, the relative influence of physician, patient, and procedure-specific factors on polyp detection is unclear. Therefore, determining how these factors contribute to adenoma and sessile serrated polyp (SSP) detection is important to contextualize measures of colonoscopy quality such as adenoma detection rate and patient outcomes. AIMS: To determine the relative contribution of physician, patient, and procedure-specific factors in total polyp, adenoma, and SSP detection rates.
METHODS: We performed a retrospective study of patients undergoing screening colonoscopy and used a two-level generalized linear mixed regression model to identify factors associated with polyp detection.
RESULTS: 7799 average risk screening colonoscopies were performed between July 2016 and October 2017. The patient factor most strongly associated with increased risk of adenoma and sessile serrated polyp detection was white race (OR 1.21, 95% CI 1.05-1.39 and OR 3.17, 95% CI 2.34-4.30, respectively). Adenomatous (OR 1.92, 95% CI 1.04-3.57) and sessile serrated polyps (OR 5.56, 95% CI 1.37-20.0) were more likely to be found during procedures performed with anesthesia care as compared to those with moderate sedation. Physician with a luminal gastrointestinal focus had increased odds of adenoma detection (OR 1.61, 95% CI 1.02-2.50).
CONCLUSIONS: In a multi-level model accounting for clustering effects, we identified patient, provider and procedural factors independently influence adenoma and sessile serrated polyp detection. Our findings suggest that to compare polyp detection rates between endoscopists, even at the same institution, risk adjustment by characteristics of the patient population and practice is necessary.
© 2020. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Adenoma detection rate; Colonoscopy quality; Screening colonoscopy; Sessile serrated polyps

Year:  2020        PMID: 32894441     DOI: 10.1007/s10620-020-06592-w

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  5 in total

1.  Factors Associated with Surveillance Adenoma and Sessile Serrated Polyp Detection Rates.

Authors:  Jennifer K Maratt; Joseph Dickens; Philip S Schoenfeld; Grace H Elta; Kenya Jackson; Daniel Rizk; Christine Erickson; Stacy B Menees
Journal:  Dig Dis Sci       Date:  2017-10-17       Impact factor: 3.199

2.  Impact of Endoscopists' Personality Traits on Adenoma and Polyp Detection Rates in Colonoscopy: A KASID Multicenter Study.

Authors:  Yunho Jung; Jae Myung Cha; Na-Hyun Lee; Young-Eun Joo; Yoo Jin Lee; Hyun Gun Kim; Seong Ran Jeon; Jeong Eun Shin; Hyo-Joon Yang; Jun Lee; Kyeong Ok Kim; Jong Wook Kim; Soo-Young Na; Sun-Jin Boo; Jae Hyun Kim; Mee Jung Han; Young Hwangbo; Kyu Chan Huh
Journal:  Dig Dis Sci       Date:  2020-03-10       Impact factor: 3.199

3.  Adenoma Detection Rate as a Quality Metric: Is It Really Out of the Endoscopists' Hands?

Authors:  Selvi Thirumurthi; William A Ross
Journal:  Dig Dis Sci       Date:  2019-12       Impact factor: 3.199

4.  Difference in Physician- and Patient-Dependent Factors Contributing to Adenoma Detection Rate and Serrated Polyp Detection Rate.

Authors:  Maryan Cavicchi; Gaëlle Tharsis; Pascal Burtin; Philippe Cattan; Franck Venezia; Gilles Tordjman; Agnès Gillet; Joëlle Samama; Karine Nahon-Uzan; David Karsenti
Journal:  Dig Dis Sci       Date:  2019-08-30       Impact factor: 3.199

5.  Gastrointestinal Symptoms Onset in COVID-19 Patients in Wuhan, China.

Authors:  Ping An; Hongbin Chen; Haixia Ren; Juan Su; Mengyao Ji; Jian Kang; Xiaoda Jiang; Yifei Yang; Jiao Li; Xiaoguang Lv; Anning Yin; Di Chen; Mingkai Chen; Zhongyin Zhou; Weiguo Dong; Yijuan Ding; Honggang Yu
Journal:  Dig Dis Sci       Date:  2020-11-12       Impact factor: 3.199

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.